These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 107338)

  • 1. Proton radiation as boost therapy for localized prostatic carcinoma.
    Shipley WU; Tepper JE; Prout GR; Verhey LJ; Mendiondo OA; Goitein M; Koehler AM; Suit HD
    JAMA; 1979 May; 241(18):1912-5. PubMed ID: 107338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protons or megavoltage X-rays as boost therapy for patients irradiated for localized prostatic carcinoma. An early phase I/II comparison.
    Duttenhaver JR; Shipley WU; Perrone T; Verhey LJ; Goitein M; Munzenrider JE; Prout GR; Parkhurst EC; Suit HD
    Cancer; 1983 May; 51(9):1599-604. PubMed ID: 6299503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.
    Shipley WU; Verhey LJ; Munzenrider JE; Suit HD; Urie MM; McManus PL; Young RH; Shipley JW; Zietman AL; Biggs PJ
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):3-12. PubMed ID: 7721636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients.
    Isacsson U; Nilsson K; Asplund S; Morhed E; Montelius A; Turesson I
    Acta Oncol; 2010 May; 49(4):500-5. PubMed ID: 20397777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of treatment plans for irradiating adenocarcinoma of the prostate.
    Luka S; Kurup R
    Med Dosim; 1995; 20(2):117-22. PubMed ID: 7632344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor response and treatment complications in radiotherapy of localized prostate cancer.
    Strnad V; Tacev T; Prokes B; Ott O; Krystof V; Svobodova M; Rasovska O; Konecny M
    Strahlenther Onkol; 1990 Nov; 166(11):728-32. PubMed ID: 2124375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial experience with the use of the proton beam at the Institute of Theoretical and Experimental Physics to treat prostatic cancer].
    Makarova GV; Matveev BP; Leonova NS; Ratner TG; Molchanov GV
    Med Radiol (Mosk); 1987 Aug; 32(8):66-70. PubMed ID: 3041165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan.
    Nihei K; Ogino T; Ishikura S; Kawashima M; Nishimura H; Arahira S; Onozawa M
    Jpn J Clin Oncol; 2005 Dec; 35(12):745-52. PubMed ID: 16314345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton therapy in Japan.
    Tsunemoto H; Morita S; Ishikawa T; Furukawa S; Kawachi K; Kanai T; Ohara H; Kitagawa T; Inada T
    Radiat Res Suppl; 1985; 8():S235-43. PubMed ID: 3003785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.
    Vargas C; Fryer A; Mahajan C; Indelicato D; Horne D; Chellini A; McKenzie C; Lawlor P; Henderson R; Li Z; Lin L; Olivier K; Keole S
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):744-51. PubMed ID: 17904306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectourethral fistula after combination radiotherapy for prostate cancer.
    Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
    Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience in the treatment of localized carcinoma of the prostate by definitive external irradiation.
    Kuten A; Nitetzky S; Tatcher M; Cohen Y; Robinson E
    Int Urol Nephrol; 1989; 21(3):325-32. PubMed ID: 2509392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation treatment planning for the localized prostatic carcinoma: methods and rationale.
    Dewit L; van der Schueren E
    Strahlentherapie; 1984 Aug; 160(8):474-84. PubMed ID: 6474521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning.
    Hug EB; Fitzek MM; Liebsch NJ; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):467-76. PubMed ID: 7852108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.
    Zietman AL; DeSilvio ML; Slater JD; Rossi CJ; Miller DW; Adams JA; Shipley WU
    JAMA; 2005 Sep; 294(10):1233-9. PubMed ID: 16160131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer.
    Vargas C; Mahajan C; Fryer A; Indelicato D; Henderson RH; McKenzie C; Horne D; Chellini A; Lawlor P; Li Z; Oliver K; Keole S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1110-6. PubMed ID: 17967305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors.
    Lee CM; Lee RJ; Handrahan DL; Sause WT
    Urology; 2005 Jan; 65(1):114-9. PubMed ID: 15667875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous course of megavoltage radiotherapy for carcinoma of the prostate.
    Weshler Z; Gez E; Pfeffer MR; Ben-Yosef R; Loeventhal E; Fuks Z
    Isr J Med Sci; 1988; 24(9-10):580-3. PubMed ID: 3144515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.